262 related articles for article (PubMed ID: 2612330)
21. Morphological and immunological heterogeneity of human ovarian neoplasms.
Harłozińska A; Rabczyński J; Bar JK; Richter R
Arch Immunol Ther Exp (Warsz); 1991; 39(4):419-29. PubMed ID: 1821619
[TBL] [Abstract][Full Text] [Related]
22. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3.
Gangopadhyay A; Bhattacharya M; Chatterjee SK; Barlow JJ; Tsukada Y
Cancer Res; 1985 Apr; 45(4):1744-52. PubMed ID: 3884144
[TBL] [Abstract][Full Text] [Related]
23. [Pancreatic cystadenoma].
Le Borgne J
Ann Chir; 1989; 43(6):451-7. PubMed ID: 2683965
[TBL] [Abstract][Full Text] [Related]
24. Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.
Pattillo RA; Story MT; Ruckert AC
Cancer Res; 1979 Apr; 39(4):1185-92. PubMed ID: 421202
[TBL] [Abstract][Full Text] [Related]
25. A new serologic diagnostic method for malignant ovarian germ cell tumors: detection of antibodies to large glycopeptides.
Higaki K; Sekiya S; Kawata M; Takamizawa H
Am J Obstet Gynecol; 1983 Dec; 147(8):974-5. PubMed ID: 6650640
[No Abstract] [Full Text] [Related]
26. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
27. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
[TBL] [Abstract][Full Text] [Related]
28. [Mucinous carcinoma-associated antigen (MCA) in ovarian cancer].
Hanzal E; Kölbl H; Gitsch G; Bieglmayer C
Gynakol Rundsch; 1990; 30 Suppl 1():68-70. PubMed ID: 2079303
[No Abstract] [Full Text] [Related]
29. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
van Nagell JR; Pletsch QA; Goldenberg DM
Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
[TBL] [Abstract][Full Text] [Related]
30. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
[TBL] [Abstract][Full Text] [Related]
31. A huge ovarian mucinous cystadenoma in a 14-year-old premenarchal girl: review on ovarian mucinous tumor in premenarchal girls.
Karaman A; Azili MN; Boduroğlu EC; Karaman I; Erdoğan D; Cavuşoğlu YH; Aslan MK; Cakmak O
J Pediatr Adolesc Gynecol; 2008 Feb; 21(1):41-4. PubMed ID: 18312801
[TBL] [Abstract][Full Text] [Related]
32. Reactivity of polyclonal and two monoclonal antibodies with cell subsets isolated from cystic fluids of ovarian serous neoplasms.
Harłozińska A; Bar JK; Rabczyński J; Bast RC; Richter R; Cisło M
Tumori; 1990 Oct; 76(5):505-10. PubMed ID: 1701581
[TBL] [Abstract][Full Text] [Related]
33. Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies.
Miotti S; Aguanno S; Canevari S; Diotti A; Orlandi R; Sonnino S; Colnaghi MI
Cancer Res; 1985 Feb; 45(2):826-32. PubMed ID: 2981614
[TBL] [Abstract][Full Text] [Related]
34. Combined immunohistochemical study of tissue polypeptide antigen and cancer antigen 125 in human ovarian tumours.
Ghazizadeh M; Sasaki Y; Oguro T; Aihara K; Tenjin H; Araki T
Histopathology; 1990 Aug; 17(2):123-8. PubMed ID: 2227836
[TBL] [Abstract][Full Text] [Related]
35. CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression.
Carico E; Chicchirichi R; Atlante M; Giovagnoli M; Vecchione A
Anticancer Res; 1995; 15(2):631-4. PubMed ID: 7763049
[TBL] [Abstract][Full Text] [Related]
36. [Imaging of benign ovarian tumors].
Rouanet JP; Maubon A; Juhan V; Meny R; Salanon AP; Daclin PY
J Radiol; 2000 Dec; 81(12 Suppl):1823-30. PubMed ID: 11173751
[TBL] [Abstract][Full Text] [Related]
37. Significance of some tumor markers in differential diagnosis of ovarian tumor.
Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical study of new monoclonal antibodies--E29, 115D8 --to an epithelial membrane antigen (EMA) in ovarian tumors].
Fujimoto I; Fukuda K; Hang SP; Hasumi K; Masubuchi K; Osamura Y; Watanabe K
Gan No Rinsho; 1987 Nov; 33(14):1798-804. PubMed ID: 2826841
[TBL] [Abstract][Full Text] [Related]
39. Immuno-histological characterization of OVS1 and OVS2 monoclonal antibodies recognizing human ovarian mucinous cystadenocarcinoma.
Neungton N; Moongkarndi P; Laohathai K; Neungton S; Juntrachotiwit P
Asian Pac J Allergy Immunol; 1992 Dec; 10(2):129-34. PubMed ID: 1284830
[TBL] [Abstract][Full Text] [Related]
40. Ultrasonography in the diagnosis of tumors of the ovary.
DeLand M; Fried A; van Nagell JR; Donaldson ES
Surg Gynecol Obstet; 1979 Mar; 148(3):346-8. PubMed ID: 419432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]